Quick Answer
Sarepta Therapeutics, Inc. reported Total Assets of $3.35 billion for fiscal year 2025.
Sarepta Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $3.35B | -15.5% |
| 2024 | $3.96B | +21.4% |
| 2023 | $3.26B | +4.4% |
| 2022 | $3.13B | -0.6% |
| 2021 | $3.15B | +5.5% |
| 2020 | $2.98B | +63.7% |
| 2019 | $1.82B | +11.0% |
| 2018 | $1.64B | +25.5% |
| 2017 | $1.31B | +208.4% |
| 2016 | $424.10M | +54.9% |
| 2015 | $273.78M | -7.2% |
| 2014 | $295.03M | +1.2% |
| 2013 | $291.57M | +42.2% |
| 2012 | $204.99M | +277.0% |
| 2011 | $54.37M | +18.3% |
| 2010 | $45.98M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.49B | -3.0% | -5.1% |
| June 30, 2025 | $3.68B | +7.5% | +6.2% |
| March 31, 2025 | $3.47B | +7.5% | -12.6% |
| December 31, 2024 | $3.96B | +21.4% | +10.1% |
| September 30, 2024 | $3.60B | +15.8% | +5.1% |
| June 30, 2024 | $3.42B | +9.5% | +6.2% |
| March 31, 2024 | $3.22B | +5.4% | -1.2% |
| December 31, 2023 | $3.26B | +4.4% | +5.0% |
- Sarepta Therapeutics, Inc. showed a decrease of -15.5% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Sarepta Therapeutics, Inc.’s total assets has grown by 7185.8% (from $45.98 million to $3.35 billion).
- The most recent figure is from Sarepta Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: